Massachusetts Eye and Ear Infirmary
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Massachusetts Eye and Ear Infirmary sits in the top decile of US sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count).
Massachusetts Eye and Ear Infirmary: 73 sponsored US clinical trials, 20 recruiting.
Massachusetts Eye and Ear Infirmary sponsors 73 registered US clinical trials on ClinicalTrials.gov, 20 of them currently recruiting, and 36 completed. 8 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spasmodic Dysphonia, with 4 trials.
Top-decile sponsor footprint
Massachusetts Eye and Ear Infirmary ranks in the top decile of sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
36 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
73 total, page 2 of 2
Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects
NCT01864291
Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial
NCT01919411
Binocular Treatment of Amblyopia Before and After Strabismus Surgery
NCT01791946
Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects
NCT01736267
Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy
NCT01605903
In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions
NCT01993654
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
NCT01456780
Study to Evaluate the Efficacy of Optical Imaging to Evaluate the Anatomy of the Developing Pediatric Vocal Fold
NCT01810107
Effects of Anti-Glaucoma Medications on the Ocular Surface
NCT01315574
Randomized Controlled Trial of Voice on Children With Vocal Nodules
NCT01255735
The Effects of Caffeinated Coffee on Intraocular Pressure
NCT01364207
Comparison of Four Different Aberrometers for Evaluation of Higher Order Visual Aberrations
NCT01230164
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
NCT01250925
Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy
NCT01415583
Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma
NCT01105065
PEMF: an Adjunct Therapy for Anterior Uveitis
NCT01154010
Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG)
NCT00824824
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
NCT00765921
Intraoperative Laryngeal Electromyography (LEMG) in Children With Vocal Fold Immobility: a Longitudinal Study
NCT00771186
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
NCT00553735
Topical Avastin for Treatment of Corneal Neovascularization
NCT00559936
Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP
NCT00550914
Sudden Deafness Treatment Trial
NCT00097448
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 9 |
| Phase 3 | 1 |
| Phase 4 | 7 |
What is open in the Massachusetts Eye and Ear Infirmary pipeline
20 recruiting of 73 indexed (27% open); 36 completed (49%).
Phase mix: 8 late (III/IV) vs 22 early (I/II) (early-phase heavy).
Top condition: Spasmodic Dysphonia (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Massachusetts Eye and Ear Infirmary: open-pipeline peers nationwide
Peers matched on 73 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
Massachusetts Eye and Ear Infirmary sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 73 trials (± recruiting share)
- Denver Health and Hospital Authority · 73 trials · 5% recruiting
- Hugo W. Moser Research Institute at Kennedy Krieger · 73 trials · 23% recruiting
- Joslin Diabetes Center · 73 trials · 10% recruiting
- Tulane University · 73 trials · 30% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Connecticut Children's Medical Center · 27% recruiting · 55 trials
- Criterium · 27% recruiting · 11 trials
- Minneapolis Heart Institute Foundation · 27% recruiting · 22 trials
- Nerviano Medical Sciences · 27% recruiting · 11 trials
Related
What to do with this Massachusetts Eye and Ear Infirmary page
73 registered trials is a research-attention snapshot, not an endorsement of Massachusetts Eye and Ear Infirmary or any single study.
- 20 of Massachusetts Eye and Ear Infirmary's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Spasmodic Dysphonia is the condition Massachusetts Eye and Ear Infirmary studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spasmodic Dysphonia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Massachusetts Eye and Ear Infirmary pipeline card: 73 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.